Aldeyra Therapeutics Statistics
 Total Valuation
 ALDX has a market cap or net worth of $302.03 million. The enterprise value is $235.67 million.
 Important Dates
 The next estimated earnings date is Thursday, November 6, 2025, after market close.
 | Earnings Date | Nov 6, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 ALDX has 60.05 million shares outstanding. The number of shares has increased by 0.86% in one year.
 | Current Share Class | 60.05M | 
| Shares Outstanding | 60.05M | 
| Shares Change (YoY) | +0.86% | 
| Shares Change (QoQ) | +0.26% | 
| Owned by Insiders (%) | 3.14% | 
| Owned by Institutions (%) | 42.20% | 
| Float | 48.63M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | 5.46 | 
| P/TBV Ratio | 5.46 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.28.
 | Current Ratio | 2.86 | 
| Quick Ratio | 2.77 | 
| Debt / Equity | 0.28 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -28.00 | 
Financial Efficiency
 Return on equity (ROE) is -65.91% and return on invested capital (ROIC) is -36.06%.
 | Return on Equity (ROE) | -65.91% | 
| Return on Assets (ROA) | -31.58% | 
| Return on Invested Capital (ROIC) | -36.06% | 
| Return on Capital Employed (ROCE) | -96.18% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$5.62M | 
| Employee Count | 9 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
  | Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -7.20% in the last 52 weeks. The beta is 0.82, so ALDX's price volatility has been lower than the market average.
 | Beta (5Y) | 0.82 | 
| 52-Week Price Change | -7.20% | 
| 50-Day Moving Average | 5.40 | 
| 200-Day Moving Average | 4.63 | 
| Relative Strength Index (RSI) | 41.52 | 
| Average Volume (20 Days) | 702,918 | 
Short Selling Information
 The latest short interest is 4.68 million, so 7.80% of the outstanding shares have been sold short.
 | Short Interest | 4.68M | 
| Short Previous Month | 5.09M | 
| Short % of Shares Out | 7.80% | 
| Short % of Float | 9.63% | 
| Short Ratio (days to cover) | 6.23 | 
Income Statement
  | Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -53.31M | 
| Pretax Income | -50.62M | 
| Net Income | -50.62M | 
| EBITDA | -53.06M | 
| EBIT | -53.31M | 
| Earnings Per Share (EPS) | -$0.85 | 
 Full Income StatementBalance Sheet
 The company has $81.92 million in cash and $15.56 million in debt, giving a net cash position of $66.36 million or $1.11 per share.
 | Cash & Cash Equivalents | 81.92M | 
| Total Debt | 15.56M | 
| Net Cash | 66.36M | 
| Net Cash Per Share | $1.11 | 
| Equity (Book Value) | 55.29M | 
| Book Value Per Share | 0.92 | 
| Working Capital | 55.03M | 
 Full Balance SheetCash Flow
  | Operating Cash Flow | -41.04M | 
| Capital Expenditures | n/a | 
| Free Cash Flow | -41.04M | 
| FCF Per Share | -$0.68 | 
 Full Cash Flow StatementMargins
  | Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 ALDX does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -0.86% | 
| Shareholder Yield | -0.86% | 
| Earnings Yield | -16.76% | 
| FCF Yield | -13.59% | 
 Analyst Forecast
 The average price target for ALDX is $9.50, which is 88.87% higher than the current price. The consensus rating is "Strong Buy".
 | Price Target | $9.50 | 
| Price Target Difference | 88.87% | 
| Analyst Consensus | Strong Buy | 
| Analyst Count | 2 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |